SlideShare una empresa de Scribd logo
1 de 39
ANTIFUNGAL
AGENTS
-classification
-MOA
-indications
-Adverse effects
Susritha.k
Pg dpt of ent
ASRAMS eluru
 Fungi

are eukaryotic, heterotrophic (not
self sustaining) organisms that live as
saprobes or parasites.

 They

are complex organisms in
comparison to bacteria.

 Fungal

infections are also called as
mycoses.


They have nucleus and
well defined nuclear
membrane, and
chromosomes.



they have rigid cell wall
composed of chitin ( N –
acetylglucosamine )



where as bacterial cell
wall is composed of
peptidoglycan .



fungal cell membrane
contains ergosterol.
Fungal infection
SUPERFICIAL

Dermatomycoses
affecting skin, hair
or nails.

SYSTEMIC
Candidiasis
cryptococosis,
Aspergillosis,

Candidiasis

Blastomycosis,
Histoplasmosis,
Coccidioidomycosi
s,
Paracoccidioidomy
cosis
Drug Classification
A) Drugs that disrupt fungal cell membrane
i) Polyenes
Amphotericin
Nystatin
Natamycin

ii) Azoles
A) Imidazole
Ketoconazole
Butaxonazole
Clotrimazole
Econazole
Miconazole
Oxiconazole
Sulconazole
B) Triazole
Fluconazole
Itraconazole
Tioconazole
iii) Allylamines

Terbinafine
Naftifine
Butenafine
vi) Echinocandins
caspofungin
B)Drugs that inhibits mitosis
Griseofulvin

C)Drugs that inhibits DNA synthesis
flucytosine
Miscellaneous

Haloprogi
Tolnaftate
Whitefield's ointment
Ciclopirox olamine
Diagram showing mechanism of action of different anti fungal durgs
POLYENE ANTIBIOTICS
 They

act by:
Binding to sterol in cell membrane.
Deformity in plasma membrane occurs

Interferes with permeability and with transport functions
This allows leakage of intracellular ions and enzymes
especially loss of intracellular k+
cell
death.

 They

bind selectively to ergosterol in
fungus but not in mammalian cell wall.
AMPHOTERICIN B


It is macrolide antibiotic large lactone ring.



Poorly absorbed orally, useful for fungal infection of gastrointestinal
tract.



Locally used in corneal ulcers, arthritis and candidial bladder
irrigation



For systemic infections given as slow I/V infusion.



Highly protein bound.



Penetration through BBB is poor but increases in inflamed meninges.



Excreted slowly via kidneys, traces found in urine for months after
cessation of drugs.



Half life 15 days
 Drug

of choice for
most systemic
infections.

 Course

of treatment
lasts 6-12 weeks.

 Dose

0.5-1
mgkgday.
ADVERSE EFFECTS:


Most serious is renal toxicity, which occurs in
80% of patients.



Hypokalaemia in 25% of patients, requiring
potassium supplementation.



Hypomagnesaemia
Anemia
Impaired hepatic function
Thrombocytopenia




Liposomal preparations of
amphotericin B(newer
preparations)





To reduce the toxicity of amphotericin B ,several new
formulations have been developed in which amphotericin B
is packaged in a lipid-associated delivery system, to assume
that they will less bind to mammalian cell.
Lipid vehicle act as a reservoir, reducing binding to human
cell.
In this way it permits a larger doses, even five times more
than colloidal preparation, they have better clearance .



Clinically they have more efficacy , less nephrotoxicity.



But these are very expensive.
Nystatin
 It

is polyene macrolide,similar in structure
to amphotericin and with same
mechanism of action.

 Too
 Not

toxic for systemic use

absorbed from GIT /skin therefore
administered orally.
 Prevent

or treat superficial candidiasis of
mouth, esophagus or intestinal tract, oral
suspension of 100,000 U/ml 4 times a day
and tablets 500,000 U are used to
decrease GIT colonization with Candida.
 Can be used in combination with
antibacterial agents and corticosteroids.
AZOLES:


a bivalent chemical group composed of two nitrogen
atoms.



They are antibacterial, antiprotozoal, anthelminthic and
antifungal.



These are group of synthetic fungistatic agents.



They have broad spectrum of activity.



Inhibit the fungal cytochrome P450 3A enzyme ,
(lanosine 14-desmethylase ),which is responsible for
converting lanosterol to ergosterol, the main sterol in the
fungal cell membrane, this alters fluidity of the
membrane, thus inhibiting the growth of fungi.
IMIDAZOLES
 Ketoconazole,
 miconazole,
 clotrimazole,
 isoconazole

,

 Tioconazole

 They

interfere with fungal oxidative enzymes to
cause lethal accumulation of hydrogen peroxide.
 they reduce the formation of ergosterol by
inhibition of fungal cytochrome P450 enzyme,
which become permeable to cellular constituent
TRIAZOLES:




Fluconazole,
itraconazole,
voriconazole



They damage the fungal cell membrane by inhibiting
enzyme desmethylase .



They are selective



Penetrate to CNS



Resistant to degradation



Cause less endocrine disturbance.
KETACONAZOLE:
 First

azole that could be given orally to treat
systemic fungal infections.

 Well

absorbed orally as acidic environment favours
its dissolution.
 Only administered orally.
 After

oral administration of 200,400 and 800 mg,
plasma conc. reaches to 4.8 and 20 ug/ml.

 Half

mg

life increases with dose and it is 7-8 hrs with 800
 Decrease

in the
ergosterol in the fungal
membrane by
ketoconazle reduces
the fungicidal action of
amphotericin.

 Oral

dose 400 mg daily.
 As

it inhibits steroid biosynthesis, several
endocrinological abnormalities may be
evident as menstrual abnormalities,
gynecomastia, decreased libido and
impotency.
 Contraindicated in pregnancy.
ITRACONAZOLE






It is a synthetic triazole
it is new drug
It lacks endocrine side effects
of ketoconazole.

It has broad spectrum
activirty



Administered orally as well as
I/V.



Do not penetrate CSF
adequately.
Dose 100 mg twice daily with
food, initially 300 mg thrice
daily as a loading dose
hypertriglyceridemia,
Hypokalaemia, hepatotoxicty





FLUCONAZOLE


It is fluorinated bistriazole.



Completely absorbed from GIT



Excellent bioavailability by oral route.



Concentration in plasma is same by
oral or I/v route
Drug interactions are less common.
It easily penetrate CSF and is a drug
of choice in cryptococcal meningitis
and coccido mycosis
Candidiasis: 200 mg on 1st day then
100 mg daily for 2 weeks.








Cryptococcosis: 400 mg daily for 8
weeks in meningitis.



Hepatic failure may lead to death



It is highly teratogenic.
Voriconazole


A new drug available in i.v and oral
fromulations.



recommended dosage is 400 mg/ day



high biological availability when given orally



hepatic metabolism predominant.



it is similar to itraconazole but more potent.
FLUCYTOSINE


Has useful activity against Candida and Cryptococcus.



it is synthetic pyrimidine antimetabolite that is often used
in combination with amphotericin B.



Mechanism of action



It is converted to antimetabolite 5-florouracil in a fungal cell.
This 5-FU inhibits thymidylate synthetase enzyme and thus
DNA synthesis.


dose 100-150 mg /kg per day divided into 4
doses.



Generally use in combination with
amphotericin



For cryptococcal meningitis in AIDS patients
Side effects:





reversible neutropenia, thrombocytopenia and
occasional bone marrow depression.
Caspofungin
 It

is echinocandin class of antifungal drugs
 it interferes with the synthesis of fungal cell wall by
inhibiting synthesis of D-glucan.
 especially useful for aspergillus and candida.
 not active orally.
 Has half life of 9-11 hours

 Adverse



effects include nausea ,vomiting, flushing
very expensive
GRISEOFULVIN


Isolated from Pencillium griseofulvum



It interacts with microtubules and interferes with mitosis.


Uses




Mycotic diseases of skin, hair (particularly for
scalp) , nail.

It is also highly effective in athlete's foot
Peripheral neuritis
 Lethargy
 mental confusion
 impairment in performance of routine task
 fatigue, vertigo ,syncope, blurred vision.

Comparison of Azoles fungistatic drugs
Topical anti fungal
preparations
 Topical








azole derivatives
Ciclopirox olamine
Naftifine
Terbinafine
Butenafine
tolnaftate
Nystatin and Amphotericin
 Amphotericin




B

Candida oesphogitis0.15-0.2mg/kg daily.
Invasive aspergillosis1-1.2mg/kg until
progression is arrested.
Candida cystitisbladder irrigation with
50ug/ml.
 Itraconazoledeep



mycosis

Divided dosage1st 3 days 200mg three
times(loading dose)
Maitainence dose200mg once daily for
12wks.

 Flucanozole


Oesophageal candidiasis







200mg 1st day.
100mg daily for 2 wks.

Coccidioial meningitis
Cryptococcal meningitis400mg daily 8wks
later 200mg for life
Future prospects
 Posaconazole

azoles.

& rabuconazole newer

Very effective in
treatment of
zygomycosis in
immunocompromised

 Nikkomycins

newer antifungals act by
inhibiting chitin synthesis.
 Sordarinsupcoming


Inhibits fungal growth by blocking
elongation factor2.

 Two



class of antifungals

new echinocandins

Micafungin
Anidulafungin

Effective in
immunocomprimised pts
against aspergillus &
candida infections.
 Recombinant

form of human granulocyte
colony stimulating factors like
 Lenogastrin

increase neutrophil count in
neutropenia pts with fungal infections.

 These

are used along with antifungal
agents to enhance their efficacy in
immunocompromised pts.
Bibliography
 Goodmans

gillmans-the pharmacological
basis of therepeutics 10th edition pg:1295.
 Principles of pharmacology –sharma h.s
pg:789-90.
 Tripati

Más contenido relacionado

La actualidad más candente (20)

Anti fungal agents
Anti fungal agentsAnti fungal agents
Anti fungal agents
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
Antifungal drugs-Antibiotics
Antifungal drugs-AntibioticsAntifungal drugs-Antibiotics
Antifungal drugs-Antibiotics
 
Anti fungal (amphotericin b)
Anti fungal (amphotericin b)Anti fungal (amphotericin b)
Anti fungal (amphotericin b)
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
1.sulfonamide final
1.sulfonamide final1.sulfonamide final
1.sulfonamide final
 
Macrolides
MacrolidesMacrolides
Macrolides
 
Penicillins
PenicillinsPenicillins
Penicillins
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
Quinolones
QuinolonesQuinolones
Quinolones
 
Tetracyclines
Tetracyclines Tetracyclines
Tetracyclines
 
Antifungal drugs Pharmacology
Antifungal drugs PharmacologyAntifungal drugs Pharmacology
Antifungal drugs Pharmacology
 
Beta lactam antibiotics(Penicillin, Cephalosporin)
Beta lactam antibiotics(Penicillin, Cephalosporin)Beta lactam antibiotics(Penicillin, Cephalosporin)
Beta lactam antibiotics(Penicillin, Cephalosporin)
 
Aminoglycoside antibiotics
Aminoglycoside antibioticsAminoglycoside antibiotics
Aminoglycoside antibiotics
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 
Macrolides
MacrolidesMacrolides
Macrolides
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Lincosamides
LincosamidesLincosamides
Lincosamides
 
Betalactum antibiotics
Betalactum antibioticsBetalactum antibiotics
Betalactum antibiotics
 

Destacado

Antivirales , Amantadina, ACICLOVIR y RIBAVIRINA
Antivirales , Amantadina, ACICLOVIR  y RIBAVIRINAAntivirales , Amantadina, ACICLOVIR  y RIBAVIRINA
Antivirales , Amantadina, ACICLOVIR y RIBAVIRINALuis Hurtado
 
Experiencia manejo drogas_uci
Experiencia manejo drogas_uciExperiencia manejo drogas_uci
Experiencia manejo drogas_uciunlobitoferoz
 
Medicamentos antivirales expo
Medicamentos antivirales expoMedicamentos antivirales expo
Medicamentos antivirales expoManuela Garcia
 
Antimicoticos y Antivirales
Antimicoticos y AntiviralesAntimicoticos y Antivirales
Antimicoticos y AntiviralesBabyMarichelle
 
Antivirales
AntiviralesAntivirales
AntiviralesFarmaFM
 
Cuidados de enfermeria para la administracion de medicamentos
Cuidados de enfermeria para la administracion de medicamentosCuidados de enfermeria para la administracion de medicamentos
Cuidados de enfermeria para la administracion de medicamentosMarisol Ganan
 
Cuidados de enfermeria en la administracion de vancomicina
Cuidados de enfermeria en la administracion de vancomicinaCuidados de enfermeria en la administracion de vancomicina
Cuidados de enfermeria en la administracion de vancomicinaevidenciaterapeutica.com
 
Cuidados de enfermeria en la administracion de citotoxicos
Cuidados de enfermeria en la administracion de citotoxicosCuidados de enfermeria en la administracion de citotoxicos
Cuidados de enfermeria en la administracion de citotoxicosevidenciaterapeutica.com
 

Destacado (17)

Antivirales , Amantadina, ACICLOVIR y RIBAVIRINA
Antivirales , Amantadina, ACICLOVIR  y RIBAVIRINAAntivirales , Amantadina, ACICLOVIR  y RIBAVIRINA
Antivirales , Amantadina, ACICLOVIR y RIBAVIRINA
 
Experiencia manejo drogas_uci
Experiencia manejo drogas_uciExperiencia manejo drogas_uci
Experiencia manejo drogas_uci
 
Antivirales parte3
Antivirales parte3Antivirales parte3
Antivirales parte3
 
Antivirales
Antivirales Antivirales
Antivirales
 
Medicamentos antivirales expo
Medicamentos antivirales expoMedicamentos antivirales expo
Medicamentos antivirales expo
 
Antimicoticos y Antivirales
Antimicoticos y AntiviralesAntimicoticos y Antivirales
Antimicoticos y Antivirales
 
Antivirales
AntiviralesAntivirales
Antivirales
 
Aciclovir
AciclovirAciclovir
Aciclovir
 
Antivirales farmaco
Antivirales farmacoAntivirales farmaco
Antivirales farmaco
 
Antivirales
AntiviralesAntivirales
Antivirales
 
Antivirales parte1
Antivirales parte1Antivirales parte1
Antivirales parte1
 
Cuidados de enfermeria para la administracion de medicamentos
Cuidados de enfermeria para la administracion de medicamentosCuidados de enfermeria para la administracion de medicamentos
Cuidados de enfermeria para la administracion de medicamentos
 
Cuidados de enfermeria en la administracion de vancomicina
Cuidados de enfermeria en la administracion de vancomicinaCuidados de enfermeria en la administracion de vancomicina
Cuidados de enfermeria en la administracion de vancomicina
 
Antivirales parte2
Antivirales parte2Antivirales parte2
Antivirales parte2
 
Cuidados de enfermeria en la administracion de citotoxicos
Cuidados de enfermeria en la administracion de citotoxicosCuidados de enfermeria en la administracion de citotoxicos
Cuidados de enfermeria en la administracion de citotoxicos
 
ITS
ITSITS
ITS
 
Clasificacion Antibioticos
Clasificacion AntibioticosClasificacion Antibioticos
Clasificacion Antibioticos
 

Similar a Antifungal agents

9 - ANTI FUNGAL DRUGS.ppt
9 - ANTI FUNGAL DRUGS.ppt9 - ANTI FUNGAL DRUGS.ppt
9 - ANTI FUNGAL DRUGS.pptLijFire
 
ANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugs
ANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugsANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugs
ANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugsGopi Krishna Rakam
 
ANTI FUNGAL DRUGS zczxfuccuufufufufuu.ppt
ANTI FUNGAL DRUGS zczxfuccuufufufufuu.pptANTI FUNGAL DRUGS zczxfuccuufufufufuu.ppt
ANTI FUNGAL DRUGS zczxfuccuufufufufuu.pptsiddarthsaini007
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugsAmira Badr
 
antifungaldrugs-150519204813-lva1-app6892 (1).pdf
antifungaldrugs-150519204813-lva1-app6892 (1).pdfantifungaldrugs-150519204813-lva1-app6892 (1).pdf
antifungaldrugs-150519204813-lva1-app6892 (1).pdfIdrisSham1
 
Class antifungal agents
Class antifungal agentsClass antifungal agents
Class antifungal agentsRaghu Prasada
 
ANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATION
ANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATIONANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATION
ANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATIONDhanashri Prakash Sonavane
 
Class antifungal agents
Class antifungal agentsClass antifungal agents
Class antifungal agentsRaghu Prasada
 
Shanmukh ppt omr
Shanmukh ppt omrShanmukh ppt omr
Shanmukh ppt omrshannu511
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agentsHamseHaybe
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agentsHamseHaybe
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agentsHamseHaybe
 
Antifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptx
Antifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptxAntifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptx
Antifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptxMuhammadAbdusSamad3
 

Similar a Antifungal agents (20)

9 - ANTI FUNGAL DRUGS.ppt
9 - ANTI FUNGAL DRUGS.ppt9 - ANTI FUNGAL DRUGS.ppt
9 - ANTI FUNGAL DRUGS.ppt
 
9 - ANTI FUNGAL DRUGS.ppt
9 - ANTI FUNGAL DRUGS.ppt9 - ANTI FUNGAL DRUGS.ppt
9 - ANTI FUNGAL DRUGS.ppt
 
ANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugs
ANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugsANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugs
ANTI FUNGAL DRUGS.ppt The ppt contains information about Antifungal drugs
 
ANTI FUNGAL DRUGS zczxfuccuufufufufuu.ppt
ANTI FUNGAL DRUGS zczxfuccuufufufufuu.pptANTI FUNGAL DRUGS zczxfuccuufufufufuu.ppt
ANTI FUNGAL DRUGS zczxfuccuufufufufuu.ppt
 
Antifungal Agent.ppt
Antifungal Agent.pptAntifungal Agent.ppt
Antifungal Agent.ppt
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
antifungaldrugs-150519204813-lva1-app6892 (1).pdf
antifungaldrugs-150519204813-lva1-app6892 (1).pdfantifungaldrugs-150519204813-lva1-app6892 (1).pdf
antifungaldrugs-150519204813-lva1-app6892 (1).pdf
 
Antifungal Drugs 3.ppt
Antifungal Drugs 3.pptAntifungal Drugs 3.ppt
Antifungal Drugs 3.ppt
 
Class antifungal agents
Class antifungal agentsClass antifungal agents
Class antifungal agents
 
Antifungal drugs
Antifungal drugs Antifungal drugs
Antifungal drugs
 
ANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATION
ANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATIONANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATION
ANTIFUNGAL AND ANTI-TUBERCULOSIS DRUGS WITH CLASSIFICATION
 
Class antifungal agents
Class antifungal agentsClass antifungal agents
Class antifungal agents
 
Shanmukh ppt omr
Shanmukh ppt omrShanmukh ppt omr
Shanmukh ppt omr
 
Antifungal drugs
Antifungal drugsAntifungal drugs
Antifungal drugs
 
Antifungal agents
Antifungal agentsAntifungal agents
Antifungal agents
 
Anti fungal drugs
Anti fungal drugsAnti fungal drugs
Anti fungal drugs
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agents
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agents
 
Antiviral agents
Antiviral agentsAntiviral agents
Antiviral agents
 
Antifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptx
Antifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptxAntifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptx
Antifungal Action Mechanism ofs of Azoles, Caspofungin and Terbinafine.pptx
 

Último

Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...EduSkills OECD
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfchloefrazer622
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104misteraugie
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactPECB
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformChameera Dedduwage
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptxVS Mahajan Coaching Centre
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...fonyou31
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxGaneshChakor2
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationnomboosow
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxheathfieldcps1
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdfQucHHunhnh
 

Último (20)

INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptxINDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
INDIA QUIZ 2024 RLAC DELHI UNIVERSITY.pptx
 
Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1Código Creativo y Arte de Software | Unidad 1
Código Creativo y Arte de Software | Unidad 1
 
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
 
Advance Mobile Application Development class 07
Advance Mobile Application Development class 07Advance Mobile Application Development class 07
Advance Mobile Application Development class 07
 
Disha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdfDisha NEET Physics Guide for classes 11 and 12.pdf
Disha NEET Physics Guide for classes 11 and 12.pdf
 
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"Mattingly "AI & Prompt Design: The Basics of Prompt Design"
Mattingly "AI & Prompt Design: The Basics of Prompt Design"
 
Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104Nutritional Needs Presentation - HLTH 104
Nutritional Needs Presentation - HLTH 104
 
Beyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global ImpactBeyond the EU: DORA and NIS 2 Directive's Global Impact
Beyond the EU: DORA and NIS 2 Directive's Global Impact
 
A Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy ReformA Critique of the Proposed National Education Policy Reform
A Critique of the Proposed National Education Policy Reform
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions  for the students and aspirants of Chemistry12th.pptxOrganic Name Reactions  for the students and aspirants of Chemistry12th.pptx
Organic Name Reactions for the students and aspirants of Chemistry12th.pptx
 
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
Ecosystem Interactions Class Discussion Presentation in Blue Green Lined Styl...
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
CARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptxCARE OF CHILD IN INCUBATOR..........pptx
CARE OF CHILD IN INCUBATOR..........pptx
 
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
Mattingly "AI & Prompt Design: Structured Data, Assistants, & RAG"
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Interactive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communicationInteractive Powerpoint_How to Master effective communication
Interactive Powerpoint_How to Master effective communication
 
The basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptxThe basics of sentences session 2pptx copy.pptx
The basics of sentences session 2pptx copy.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
1029-Danh muc Sach Giao Khoa khoi 6.pdf
1029-Danh muc Sach Giao Khoa khoi  6.pdf1029-Danh muc Sach Giao Khoa khoi  6.pdf
1029-Danh muc Sach Giao Khoa khoi 6.pdf
 

Antifungal agents

  • 2.  Fungi are eukaryotic, heterotrophic (not self sustaining) organisms that live as saprobes or parasites.  They are complex organisms in comparison to bacteria.  Fungal infections are also called as mycoses.
  • 3.  They have nucleus and well defined nuclear membrane, and chromosomes.  they have rigid cell wall composed of chitin ( N – acetylglucosamine )  where as bacterial cell wall is composed of peptidoglycan .  fungal cell membrane contains ergosterol.
  • 4. Fungal infection SUPERFICIAL Dermatomycoses affecting skin, hair or nails. SYSTEMIC Candidiasis cryptococosis, Aspergillosis, Candidiasis Blastomycosis, Histoplasmosis, Coccidioidomycosi s, Paracoccidioidomy cosis
  • 5. Drug Classification A) Drugs that disrupt fungal cell membrane i) Polyenes Amphotericin Nystatin Natamycin ii) Azoles A) Imidazole Ketoconazole Butaxonazole Clotrimazole Econazole Miconazole Oxiconazole Sulconazole B) Triazole Fluconazole Itraconazole Tioconazole
  • 7. B)Drugs that inhibits mitosis Griseofulvin C)Drugs that inhibits DNA synthesis flucytosine Miscellaneous Haloprogi Tolnaftate Whitefield's ointment Ciclopirox olamine
  • 8. Diagram showing mechanism of action of different anti fungal durgs
  • 9. POLYENE ANTIBIOTICS  They act by: Binding to sterol in cell membrane. Deformity in plasma membrane occurs Interferes with permeability and with transport functions This allows leakage of intracellular ions and enzymes especially loss of intracellular k+ cell death.  They bind selectively to ergosterol in fungus but not in mammalian cell wall.
  • 10. AMPHOTERICIN B  It is macrolide antibiotic large lactone ring.  Poorly absorbed orally, useful for fungal infection of gastrointestinal tract.  Locally used in corneal ulcers, arthritis and candidial bladder irrigation  For systemic infections given as slow I/V infusion.  Highly protein bound.  Penetration through BBB is poor but increases in inflamed meninges.  Excreted slowly via kidneys, traces found in urine for months after cessation of drugs.  Half life 15 days
  • 11.  Drug of choice for most systemic infections.  Course of treatment lasts 6-12 weeks.  Dose 0.5-1 mgkgday.
  • 12. ADVERSE EFFECTS:  Most serious is renal toxicity, which occurs in 80% of patients.  Hypokalaemia in 25% of patients, requiring potassium supplementation.  Hypomagnesaemia Anemia Impaired hepatic function Thrombocytopenia   
  • 13. Liposomal preparations of amphotericin B(newer preparations)    To reduce the toxicity of amphotericin B ,several new formulations have been developed in which amphotericin B is packaged in a lipid-associated delivery system, to assume that they will less bind to mammalian cell. Lipid vehicle act as a reservoir, reducing binding to human cell. In this way it permits a larger doses, even five times more than colloidal preparation, they have better clearance .  Clinically they have more efficacy , less nephrotoxicity.  But these are very expensive.
  • 14.
  • 15. Nystatin  It is polyene macrolide,similar in structure to amphotericin and with same mechanism of action.  Too  Not toxic for systemic use absorbed from GIT /skin therefore administered orally.
  • 16.  Prevent or treat superficial candidiasis of mouth, esophagus or intestinal tract, oral suspension of 100,000 U/ml 4 times a day and tablets 500,000 U are used to decrease GIT colonization with Candida.  Can be used in combination with antibacterial agents and corticosteroids.
  • 17. AZOLES:  a bivalent chemical group composed of two nitrogen atoms.  They are antibacterial, antiprotozoal, anthelminthic and antifungal.  These are group of synthetic fungistatic agents.  They have broad spectrum of activity.  Inhibit the fungal cytochrome P450 3A enzyme , (lanosine 14-desmethylase ),which is responsible for converting lanosterol to ergosterol, the main sterol in the fungal cell membrane, this alters fluidity of the membrane, thus inhibiting the growth of fungi.
  • 18. IMIDAZOLES  Ketoconazole,  miconazole,  clotrimazole,  isoconazole ,  Tioconazole  They interfere with fungal oxidative enzymes to cause lethal accumulation of hydrogen peroxide.  they reduce the formation of ergosterol by inhibition of fungal cytochrome P450 enzyme, which become permeable to cellular constituent
  • 19. TRIAZOLES:    Fluconazole, itraconazole, voriconazole  They damage the fungal cell membrane by inhibiting enzyme desmethylase .  They are selective  Penetrate to CNS  Resistant to degradation  Cause less endocrine disturbance.
  • 20. KETACONAZOLE:  First azole that could be given orally to treat systemic fungal infections.  Well absorbed orally as acidic environment favours its dissolution.  Only administered orally.  After oral administration of 200,400 and 800 mg, plasma conc. reaches to 4.8 and 20 ug/ml.  Half mg life increases with dose and it is 7-8 hrs with 800
  • 21.
  • 22.  Decrease in the ergosterol in the fungal membrane by ketoconazle reduces the fungicidal action of amphotericin.  Oral dose 400 mg daily.
  • 23.  As it inhibits steroid biosynthesis, several endocrinological abnormalities may be evident as menstrual abnormalities, gynecomastia, decreased libido and impotency.  Contraindicated in pregnancy.
  • 24. ITRACONAZOLE     It is a synthetic triazole it is new drug It lacks endocrine side effects of ketoconazole. It has broad spectrum activirty  Administered orally as well as I/V.  Do not penetrate CSF adequately. Dose 100 mg twice daily with food, initially 300 mg thrice daily as a loading dose hypertriglyceridemia, Hypokalaemia, hepatotoxicty   FLUCONAZOLE  It is fluorinated bistriazole.  Completely absorbed from GIT  Excellent bioavailability by oral route.  Concentration in plasma is same by oral or I/v route Drug interactions are less common. It easily penetrate CSF and is a drug of choice in cryptococcal meningitis and coccido mycosis Candidiasis: 200 mg on 1st day then 100 mg daily for 2 weeks.     Cryptococcosis: 400 mg daily for 8 weeks in meningitis.  Hepatic failure may lead to death  It is highly teratogenic.
  • 25. Voriconazole  A new drug available in i.v and oral fromulations.  recommended dosage is 400 mg/ day  high biological availability when given orally  hepatic metabolism predominant.  it is similar to itraconazole but more potent.
  • 26. FLUCYTOSINE  Has useful activity against Candida and Cryptococcus.  it is synthetic pyrimidine antimetabolite that is often used in combination with amphotericin B.  Mechanism of action   It is converted to antimetabolite 5-florouracil in a fungal cell. This 5-FU inhibits thymidylate synthetase enzyme and thus DNA synthesis.
  • 27.  dose 100-150 mg /kg per day divided into 4 doses.  Generally use in combination with amphotericin  For cryptococcal meningitis in AIDS patients Side effects:   reversible neutropenia, thrombocytopenia and occasional bone marrow depression.
  • 28. Caspofungin  It is echinocandin class of antifungal drugs  it interferes with the synthesis of fungal cell wall by inhibiting synthesis of D-glucan.  especially useful for aspergillus and candida.  not active orally.  Has half life of 9-11 hours  Adverse  effects include nausea ,vomiting, flushing very expensive
  • 29.
  • 30. GRISEOFULVIN  Isolated from Pencillium griseofulvum  It interacts with microtubules and interferes with mitosis.
  • 31.  Uses   Mycotic diseases of skin, hair (particularly for scalp) , nail. It is also highly effective in athlete's foot Peripheral neuritis  Lethargy  mental confusion  impairment in performance of routine task  fatigue, vertigo ,syncope, blurred vision. 
  • 32. Comparison of Azoles fungistatic drugs
  • 33. Topical anti fungal preparations  Topical       azole derivatives Ciclopirox olamine Naftifine Terbinafine Butenafine tolnaftate Nystatin and Amphotericin
  • 34.  Amphotericin    B Candida oesphogitis0.15-0.2mg/kg daily. Invasive aspergillosis1-1.2mg/kg until progression is arrested. Candida cystitisbladder irrigation with 50ug/ml.
  • 35.  Itraconazoledeep   mycosis Divided dosage1st 3 days 200mg three times(loading dose) Maitainence dose200mg once daily for 12wks.  Flucanozole  Oesophageal candidiasis     200mg 1st day. 100mg daily for 2 wks. Coccidioial meningitis Cryptococcal meningitis400mg daily 8wks later 200mg for life
  • 36. Future prospects  Posaconazole azoles. & rabuconazole newer Very effective in treatment of zygomycosis in immunocompromised  Nikkomycins newer antifungals act by inhibiting chitin synthesis.
  • 37.  Sordarinsupcoming  Inhibits fungal growth by blocking elongation factor2.  Two   class of antifungals new echinocandins Micafungin Anidulafungin Effective in immunocomprimised pts against aspergillus & candida infections.
  • 38.  Recombinant form of human granulocyte colony stimulating factors like  Lenogastrin increase neutrophil count in neutropenia pts with fungal infections.  These are used along with antifungal agents to enhance their efficacy in immunocompromised pts.
  • 39. Bibliography  Goodmans gillmans-the pharmacological basis of therepeutics 10th edition pg:1295.  Principles of pharmacology –sharma h.s pg:789-90.  Tripati